| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $9.8B | $9.6B | $7.1B | $6.3B | $5.6B |
| Cost of Revenue | $6.4B | $6.2B | $4.5B | $4.1B | $3.6B |
| Gross Profit | $3.4B | $3.4B | $2.6B | $2.3B | $2.0B |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $2.8B | $2.9B | $1.9B | $1.6B | $1.4B |
| Operating Income | $-0.9B | $0.6B | $0.7B | $0.6B | $0.6B |
| Net Income | $-1.3B | $0.3B | $0.3B | $0.4B | $0.4B |
| EPS (Basic) | $-20.36 | $3.72 | $5.72 | $8.34 | $7.78 |
| EPS (Diluted) | $-20.36 | $3.71 | $5.70 | $8.28 | $7.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $10.8B | $12.0B | $12.5B | $6.7B | $5.0B |
| Current Assets | $3.1B | $2.8B | $2.9B | $1.8B | $1.5B |
| Cash & Equivalents | $0.3B | $0.2B | $0.3B | $0.1B | $0.2B |
| Total Liabilities | $8.0B | $8.0B | $8.3B | $4.0B | $2.4B |
| Current Liabilities | $2.2B | $2.0B | $2.1B | $1.1B | $1.0B |
| Stockholders' Equity | $2.7B | $4.0B | $4.1B | $2.7B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.7B | $0.7B | $0.6B | $0.5B |
| Investing Cash Flow | $-0.3B | $-0.2B | $-2.1B | $-1.8B | $-0.1B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.5B | $-0.5B | $1.8B | $1.2B | $-0.4B |